84bd90f5-4a1f-42a8-8eb1-5cb062a0b6ac.png
"Advancements in Acute Ischemic Stroke Therapeutics Market CAGR of 4.6 %: A Ray of Hope for Stroke Patients", Says Market.us
September 25, 2023 09:03 ET | Market.Us
New York, Sept. 25, 2023 (GLOBE NEWSWIRE) -- According to a recent report by Market.us, the Global Acute Ischemic Stroke Therapeutics Market size is expected to be worth around USD 14.0 Billion by...
Transparency Market Research
PET-CT Scanner Devices Market to Exceed USD 310.4 million by 2031, Expanding at a CAGR of 3.1% Says, Transparency Market Research
September 20, 2023 12:30 ET | Transparency Market Research
Wilmington, Delaware, United States, Sept. 20, 2023 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The global PET-CT scanner devices market is projected to flourish at a CAGR of 3.1% from...
URIS Neuromodulation System
STIMVIA Unveils Innovative Solution to Transform CNS Disorder Treatments at TechCrunch Disrupt 2023
September 20, 2023 12:00 ET | STIMVIA s.r.o.
SAN FRANCISCO, Sept. 20, 2023 (GLOBE NEWSWIRE) -- STIMVIA, a pioneer medical technology company, introduces an effective non-invasive neuromodulation treatment, URIS®, addressing deep brain...
AB Science fait une
AB Science fait une mise au point sur le calendrier de l’EMA concernant l'examen de la demande d'autorisation de mise sur le marché du masitinib dans la SLA
September 18, 2023 12:05 ET | AB Science
COMMUNIQUE DE PRESSE AB SCIENCE FAIT LE POINT SUR LE CALENDRIER DE L'AGENCE EUROPÉENNE DES MÉDICAMENTS CONCERNANT L'EXAMEN DE LA DEMANDE D'AUTORISATION DE MISE SUR LE MARCHÉ DU MASITINIB DANS LA...
AB Science provides
AB Science provides an update on the EMA timetable for examination of the masitinib marketing authorization application in ALS
September 18, 2023 12:05 ET | AB Science
PRESS RELEASE AB SCIENCE PROVIDES AN UPDATE ON THE EUROPEAN MEDICINES AGENCY'S TIMETABLE FOR EXAMINATION OF THE MARKETING AUTHORIZATION APPLICATION OF MASITINIB IN AMYOTROPHIC LATERAL SCLEROSIS ...
Global Market for Intracranial Aneurysm
Key Competitors like Medtronic and Stryker Drive Growth in the Global Intracranial Aneurysm Market, Valued at $1.2 Billion in 2022
September 14, 2023 06:23 ET | Research and Markets
Dublin, Sept. 14, 2023 (GLOBE NEWSWIRE) -- The "Intracranial Aneurysm - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. The Global Intracranial...
World Hydrocephalus Day Logo
Inaugural World Hydrocephalus Day
September 07, 2023 08:40 ET | Hydrocephalus Association
Bethesda, MD, Sept. 07, 2023 (GLOBE NEWSWIRE) -- On September 20, 2023, the world will come together to observe the inaugural World Hydrocephalus Day, a day dedicated to raising awareness about...
Transparency Market Research
North America Pharmaceutical Contract Sales Outsourcing [CSO] market Predicted to Reach USD 5.2 billion by 2031, Garnering Over 7% CAGR: TMR Report
September 07, 2023 07:08 ET | Transparency Market Research
Wilmington, Delaware, United States, Sept. 07, 2023 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The North America market for pharmaceutical contract sales outsourcing [CSO] was estimated...
Picture1.jpg
Globally Recognized Expert in Rare Neurologic Diseases, Dr. Michael Levy, Joins Trethera Scientific Advisory Board
September 05, 2023 10:55 ET | Trethera Corporation
LOS ANGELES, Sept. 05, 2023 (GLOBE NEWSWIRE) -- Trethera Corporation, a clinical stage biopharmaceutical company committed to developing novel drugs targeting nucleotide metabolism for the treatment...
Folia Health Announces Expansion of HD, MS, MG cohorts
Folia Health Reinforces Commitment to Autoimmune and Neurological Conditions: Announcing the Expansion of Multiple Sclerosis, Huntington's Disease, and Myasthenia Gravis User Cohorts
September 05, 2023 09:00 ET | Folia Health
BOSTON, Sept. 05, 2023 (GLOBE NEWSWIRE) -- Folia Health, a patient-focused health technology company, proudly announces a user cohort expansion of 3 conditions of great unmet need: Multiple...